当前位置:首页 - 行情中心 - 智飞生物(300122) - 财务分析 - 现金流量表

智飞生物

(300122)

  

流通市值:180.04亿  总市值:304.73亿
流通股本:14.14亿   总股本:23.94亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,877,325,0042,053,435,486.3214,680,558,384.8310,955,411,456.3
  收到的税费返还1,762,966.61,546,975.24406,133.03406,133.03
  收到其他与经营活动有关的现金131,728,874.63103,102,357.04348,560,940.09169,973,323.07
  经营活动现金流入小计5,010,816,845.232,158,084,818.615,029,525,457.9511,125,790,912.4
  购买商品、接受劳务支付的现金1,318,928,257.41930,076,569.085,467,257,130.064,475,776,499.6
  支付给职工以及为职工支付的现金918,021,013.85538,908,087.641,785,937,410.711,358,618,838.08
  支付的各项税费167,101,408.89103,402,756.77444,345,468.94339,675,547.02
  支付其他与经营活动有关的现金632,423,012.63307,628,110.32,164,665,764.551,966,701,133.13
  经营活动现金流出小计3,036,473,692.781,880,015,523.799,862,205,774.268,140,772,017.83
  经营活动产生的现金流量净额1,974,343,152.45278,069,294.815,167,319,683.692,985,018,894.57
二、投资活动产生的现金流量:
  收回投资收到的现金--5,650,0004,000,000
  处置固定资产、无形资产和其他长期资产收回的现金净额24,93020,0006,941,779.96,835,079.9
  收到的其他与投资活动有关的现金--76,653,395.9276,938,380.01
  投资活动现金流入小计24,93020,00089,245,175.8287,773,459.91
  购建固定资产、无形资产和其他长期资产支付的现金199,803,879.07102,111,213.21619,186,865.2462,338,343.65
  投资支付的现金16,643,221.44---
  支付其他与投资活动有关的现金--65,000,00065,000,000
  投资活动现金流出小计216,447,100.51102,111,213.21684,186,865.2527,338,343.65
  投资活动产生的现金流量净额-216,422,170.51-102,091,213.21-594,941,689.38-439,564,883.74
三、筹资活动产生的现金流量:
  取得借款收到的现金7,999,713,375.147,985,500,00013,347,907,154.5612,997,907,154.56
  收到其他与筹资活动有关的现金79,709,090.34217,1765,543,763.985,543,763.98
  筹资活动现金流入小计8,079,422,465.487,985,717,17613,353,450,918.5413,003,450,918.54
  偿还债务支付的现金10,069,210,295.318,937,782,848.4717,640,883,864.4115,472,699,926.41
  分配股利、利润或偿付利息支付的现金199,648,376.1115,158,049.99344,806,186.96267,017,904.33
  支付其他与筹资活动有关的现金206,773,342.518,026,977.82100,560,885.3618,030,152.78
  筹资活动现金流出小计10,475,632,013.929,060,967,876.2818,086,250,936.7315,757,747,983.52
  筹资活动产生的现金流量净额-2,396,209,548.44-1,075,250,700.28-4,732,800,018.19-2,754,297,064.98
四、汇率变动对现金及现金等价物的影响-475,442.49-16,911,711.49-687,237.77-407,575.19
五、现金及现金等价物净增加额-638,764,008.99-916,184,330.17-161,109,261.65-209,250,629.34
  加:期初现金及现金等价物余额2,542,960,105.312,542,960,105.312,704,069,366.962,704,069,366.96
  期末现金及现金等价物余额1,904,196,096.321,626,775,775.142,542,960,105.312,494,818,737.62
补充资料:
  净利润-820,337,587.68--14,745,264,578.46-
  资产减值准备-190,587,294.03-14,128,158,835.41-
  固定资产和投资性房地产折旧238,660,178.62-454,483,762.7-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧238,660,178.62-454,483,762.7-
  无形资产摊销27,586,205.96-47,638,923.69-
  长期待摊费用摊销12,203,428.47-19,171,476.87-
  处置固定资产、无形资产和其他长期资产的损失-3,107.74--5,880,932.83-
  固定资产报废损失87,311.67-377,197.29-
  公允价值变动损失--14,221,154.72-
  财务费用165,876,173.11-320,216,154.03-
  投资损失2,314,595.19--13,903.16-
  递延所得税-198,989,539.68--2,739,062,471.7-
  其中:递延所得税资产减少-194,431,222.84--2,730,416,491.8-
    递延所得税负债增加-4,558,316.84--8,645,979.9-
  存货的减少2,790,924,647.2-3,621,815,564.67-
  经营性应收项目的减少304,260,315.31-4,906,833,752.15-
  经营性应付项目的增加-721,758,644.02--868,543,909.5-
  现金的期末余额1,904,196,096.32-2,542,960,105.31-
  减:现金的期初余额2,542,960,105.31-2,704,069,366.96-
  现金及现金等价物的净增加额-638,764,008.99--161,109,261.65-
公告日期2026-08-292026-04-282026-04-282025-10-30
审计意见(境内)标准无保留意见
TOP↑